WATSON 3159 (Ursodiol 300 mg)
Pill imprint WATSON 3159 has been identified as Ursodiol 300 mg.
Ursodiol is used in the treatment of biliary cirrhosis; gallbladder disease; nonalcoholic fatty liver disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy. Ursodiol 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 3159 (Ursodiol 300 mg)
- 300 mg
- 22.00 mm
- Prescription only
- Drug Class:
- Gallstone solubilizing agents
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|68084-0213||Amerisource Health Services|
Note: Inactive ingredients may vary.
Ursodiol is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...